Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.48 |
| ▸ | SMPD1 | P17405 | 3/20 | 0.40 |
| ▸ | PLA2G2D | Q9UNK4 | 1/20 | 0.39 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.38 |
| ▸ | LPAR3 | Q9UBY5 | 2/20 | 0.38 |
| ▸ | S1PR2 | O95136 | 5/20 | 0.36 |
| ▸ | S1PR1 | P21453 | 5/20 | 0.36 |
| ▸ | S1PR3 | Q99500 | 5/20 | 0.36 |
| ▸ | S1PR4 | O95977 | 4/20 | 0.36 |
| ▸ | LAP3 | P28838 | 1/20 | 0.35 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.34 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8722280 | 0.84 | PLA2G2C (0.66) | PLA2G2CPLA2G2DLPAR1LPAR3 | |
| SCHEMBL7554036 | 0.83 | PLA2G2C (0.51) | PLA2G2CSMPD1PLA2G2DLPAR1LPAR3 | |
| SCHEMBL2523588 | 0.82 | PLA2G2C (0.64) | PLA2G2CPLA2G2DLPAR1LPAR3 | |
| SCHEMBL7204294 | 0.79 | PRKCA (0.56) | LPAR1LPAR3 | |
| SCHEMBL6254776 | 0.79 | PRKCA (0.56) | LPAR1LPAR3 | |
| SCHEMBL14659956 | 0.79 | PRKCA (0.56) | LPAR1LPAR3 | |
| SCHEMBL1962685 | 0.77 | PLA2G2C (0.53) | PLA2G2CLPAR1LPAR3 | |
| SCHEMBL2233210 | 0.77 | PLA2G2C (0.53) | PLA2G2CLPAR1LPAR3 | |
| SCHEMBL18670474 | 0.77 | PLA2G2C (0.47) | PLA2G2CLPAR3S1PR2S1PR1S1PR3 | |
| SCHEMBL10607739 | 0.77 | PLA2G2C (0.74) | PLA2G2CPLA2G2DLPAR1LPAR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2007053800-A2 | CHARGE-MODIFIED LYSOZYME ANTIMICROBIAL COMPOSITIONS, SURFACTANTS, AND METHODS FOR INFECTIONS AND CYSTIC FIBROSIS | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2007-05-10 | — | — | WO | disclosed |
| EP-0958380-A4 | MACROMOLECULE-LIPID COMPLEXES AND METHODS FOR MAKING AND USING | UNIV CALIFORNIA (US) | 2004-03-17 | — | — | EP | disclosed |
| WO-2000000033-A1 | MACROMOLECULE-LIPID COMPLEXES AND METHODS FOR MAKING AND USING | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2000-01-06 | — | — | WO | disclosed |
| EP-0958380-A1 | MACROMOLECULE-LIPID COMPLEXES AND METHODS FOR MAKING AND USING | The Regents of The University of California (US) | 1999-11-24 | — | — | EP | disclosed |
| WO-1998024936-A9 | MACROMOLECULE-LIPID COMPLEXES AND METHODS FOR MAKING AND USING | — | 1998-10-01 | — | — | WO | disclosed |
| WO-1998024936-A1 | MACROMOLECULE-LIPID COMPLEXES AND METHODS FOR MAKING AND USING | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1998-06-11 | — | — | WO | disclosed |